Free Trial
Yatin Suneja

Yatin Suneja Analyst Performance

Biotechnology Research Analyst - Specializes in I&I, CNS at Guggenheim

Yatin Suneja is a stock analyst at Guggenheim in the medical sector, covering 43 publicly traded companies. Over the past year, Yatin Suneja has issued 80 stock ratings, including strong buy, buy, and hold recommendations. While full access to Yatin Suneja's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Yatin Suneja's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
143 Last 10 Years
Buy Recommendations
86.71% 124 Buy Ratings
Companies Covered
43 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.7%1 ratings
Buy86.0%123 ratings
Hold13.3%19 ratings
Sell0.0%0 ratings

Out of 143 total stock ratings issued by Yatin Suneja at Guggenheim, the majority (86.0%) have been Buy recommendations, followed by 13.3% Hold and 0.7% Strong Buy.

Exchange Coverage

ExchangePercentageCount
NASDAQ
97.7% of companies on NASDAQ
42 companies
NYSE
2.3% of companies on NYSE
1 company

Yatin Suneja, an analyst at Guggenheim, currently covers 43 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
43 companies
100.0%

Yatin Suneja of Guggenheim specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
35 companies
81.4%
MED - DRUGS
5 companies
11.6%
PHARMACEUTICAL PREPARATIONS
2 companies
4.7%
BIOTECHNOLOGY
1 company
2.3%

About Yatin Suneja

Mr. Suneja is a Senior Managing Director and Equity Research Analyst covering the Biotechnology sector, with over 16 years of experience in equity research. Since joining Guggenheim in 2018, he has provided in-depth analysis and investment insights on biotechnology companies, with a particular focus on those in the immunology, neurology, and inflammatory (INI) space. Previously, he was a Managing Director at SunTrust Robinson Humphrey and a Vice President at Cowen & Company, both specializing in biotechnology equity research. He began his career in Corporate Banking at Bank of America. Mr. Suneja holds an M.B.A. from Syracuse University and a B.Com from PGDAV College, University of Delhi.
Follow on LinkedIn

Yatin Suneja's Ratings History at Guggenheim

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Climb Bio, Inc. stock logo
CLYM
Climb Bio
6/8/2026Initiated Coverage$10.55$35.00Buy
Climb Bio, Inc. stock logo
CLYM
Climb Bio
6/8/2026Initiated Coverage$10.77$35.00Buy
Oculis Holding AG stock logo
OCS
Oculis
6/1/2026Lower Price Target$22.70$45.00Buy
Roivant Sciences Ltd. stock logo
ROIV
Roivant Sciences
5/26/2026Boost Price Target$29.96$36.00Buy
Immunovant, Inc. stock logo
IMVT
Immunovant
5/26/2026Boost Price Target$34.15$62.00Buy
Oculis Holding AG stock logo
OCS
Oculis
5/20/2026Initiated Coverage$27.91$75.00Buy
Oculis Holding AG stock logo
OCS
Oculis
5/20/2026Upgrade$31.00Strong-Buy
Alumis Inc. stock logo
ALMS
Alumis
5/15/2026Boost Price Target$24.63$34.00Buy
argenex SE stock logo
ARGX
argenex
5/8/2026Boost Price Target$787.31$1,135.00Buy
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
5/6/2026Reiterated Rating$144.75$175.00Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
5/4/2026Boost Price Target$227.50$260.00Buy
DBV Technologies S.A. stock logo
DBVT
DBV Technologies
5/4/2026Reiterated Rating$19.10$51.00Buy
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
5/1/2026Boost Price Target$704.44$995.00Buy
Biogen Inc. stock logo
BIIB
Biogen
4/30/2026Boost Price Target$194.38$260.00Buy
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
4/27/2026Set Price Target$80.91$200.00Buy
InflaRx N.V. stock logo
IFRX
InflaRx
4/21/2026Reiterated Rating$1.63$14.00Buy
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
4/13/2026Reiterated Rating$61.89$125.00Buy
Neumora Therapeutics, Inc. stock logo
NMRA
Neumora Therapeutics
3/31/2026Reiterated Rating$1.93$14.00Buy
DBV Technologies S.A. stock logo
DBVT
DBV Technologies
3/27/2026Reiterated Rating$20.21$51.00Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
3/25/2026Boost Price Target$158.75$245.00Buy
Immunic, Inc. stock logo
IMUX
Immunic
3/24/2026Initiated Coverage$11.70$70.00Buy
Cabaletta Bio, Inc. stock logo
CABA
Cabaletta Bio
3/24/2026Boost Price Target$2.70$16.00Buy
InflaRx N.V. stock logo
IFRX
InflaRx
3/20/2026Lower Price Target$0.91$14.00Buy
Zenas BioPharma, Inc. stock logo
ZBIO
Zenas BioPharma
3/16/2026Boost Price Target$23.23$55.00Buy
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
3/13/2026Reiterated Rating$31.99$60.00Buy
Adicet Bio, Inc. stock logo
ACET
Adicet Bio
3/13/2026Lower Price Target$7.04$100.00Buy
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
3/9/2026Reiterated Rating$62.63$90.00Buy
Sionna Therapeutics, Inc. stock logo
SION
Sionna Therapeutics
3/2/2026Boost Price Target$33.68$50.00Buy
argenex SE stock logo
ARGX
argenex
2/27/2026Lower Price Target$771.53$1,120.00Buy
Phathom Pharmaceuticals, Inc. stock logo
PHAT
Phathom Pharmaceuticals
2/27/2026Boost Price Target$12.94$25.00Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
2/24/2026Boost Price Target$174.76$220.00Buy
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
2/10/2026Reiterated Rating$319.54$800.00Buy
Biogen Inc. stock logo
BIIB
Biogen
2/9/2026Boost Price Target$201.18$246.00Buy
Immunovant, Inc. stock logo
IMVT
Immunovant
2/9/2026Boost Price Target$27.05$44.00Buy
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
2/9/2026Boost Price Target$784.43$975.00Buy
Stoke Therapeutics, Inc. stock logo
STOK
Stoke Therapeutics
2/5/2026Initiated Coverage$32.00$60.00Buy
Stoke Therapeutics, Inc. stock logo
STOK
Stoke Therapeutics
2/5/2026Initiated Coverage$32.40$60.00Buy
Avalo Therapeutics, Inc. stock logo
AVTX
Avalo Therapeutics
2/2/2026Initiated Coverage$15.11$50.00Buy
Rapt Therapeutics stock logo
RAPT
Rapt Therapeutics
1/20/2026Downgrade$57.52Neutral
Alumis Inc. stock logo
ALMS
Alumis
1/7/2026Boost Price Target$16.23$32.00Buy
Your $29.97 book is free today (Ad)

Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.tc pixel

Normally $29.97. Today it's free. Grab your copy now.
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
1/2/2026Reiterated Rating$177.09$205.00Buy
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
12/29/2025Reiterated Rating$301.40Buy
SAB Biotherapeutics, Inc. stock logo
SABS
SAB Biotherapeutics
12/19/2025Initiated Coverage$3.95$15.00Buy
SAB Biotherapeutics, Inc. stock logo
SABS
SAB Biotherapeutics
12/19/2025Initiated Coverage$3.84$15.00Buy
Immunovant, Inc. stock logo
IMVT
Immunovant
12/18/2025Reiterated Rating$26.98$41.00Buy
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
12/18/2025Reiterated Rating$45.60Buy
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
12/18/2025Reiterated Rating$110.82$175.00Buy
DBV Technologies S.A. stock logo
DBVT
DBV Technologies
12/17/2025Reiterated Rating$17.98$51.00Buy
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
12/9/2025Reiterated Rating$270.98$760.00Buy
DBV Technologies S.A. stock logo
DBVT
DBV Technologies
12/3/2025Initiated Coverage$12.90$35.00Buy
DBV Technologies S.A. stock logo
DBVT
DBV Technologies
12/3/2025Initiated Coverage$12.99$35.00Buy
Roivant Sciences Ltd. stock logo
ROIV
Roivant Sciences
11/14/2025Reiterated Rating$20.56$25.00Buy
InflaRx N.V. stock logo
IFRX
InflaRx
11/10/2025Boost Price Target$1.23$22.00Buy
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
11/6/2025Reiterated Rating$172.35$540.00Buy
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
11/5/2025Boost Price Target$36.13$100.00Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
11/4/2025Boost Price Target$134.39$205.00Buy
Phathom Pharmaceuticals, Inc. stock logo
PHAT
Phathom Pharmaceuticals
10/30/2025Reiterated Rating$13.31$20.00Buy
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
10/29/2025Boost Price Target$654.48$865.00Buy
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
10/27/2025Initiated Coverage$27.25$60.00Buy
Rapt Therapeutics stock logo
RAPT
Rapt Therapeutics
10/27/2025Initiated Coverage$29.53$70.00Buy
Neumora Therapeutics, Inc. stock logo
NMRA
Neumora Therapeutics
10/27/2025Upgrade$2.63$14.00Buy
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
10/16/2025Set Price Target$189.69$350.00Buy
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
10/10/2025Boost Price Target$90.61$150.00Buy
Adicet Bio, Inc. stock logo
ACET
Adicet Bio
10/8/2025Boost Price Target$13.65$128.00Buy
MoonLake Immunotherapeutics stock logo
MLTX
MoonLake Immunotherapeutics
9/30/2025Lower Price Target$6.24$20.00Buy
Adicet Bio, Inc. stock logo
ACET
Adicet Bio
9/19/2025Reiterated Rating$12.97$112.00Buy
argenex SE stock logo
ARGX
argenex
9/18/2025Reiterated Rating$734.77$1,070.00Buy
Roivant Sciences Ltd. stock logo
ROIV
Roivant Sciences
9/18/2025Boost Price Target$15.42$21.00Buy
Tourmaline Bio, Inc. stock logo
TRML
Tourmaline Bio
9/10/2025Reiterated Rating$47.64$48.00Neutral
Tourmaline Bio, Inc. stock logo
TRML
Tourmaline Bio
9/9/2025Downgrade$47.64Hold
Dianthus Therapeutics, Inc. stock logo
DNTH
Dianthus Therapeutics
9/9/2025Boost Price Target$31.80$100.00Buy
Forte Biosciences, Inc. stock logo
FBRX
Forte Biosciences
8/18/2025Initiated Coverage$11.57$75.00Buy
Forte Biosciences, Inc. stock logo
FBRX
Forte Biosciences
8/18/2025Initiated Coverage$11.49$75.00Buy
Tourmaline Bio, Inc. stock logo
TRML
Tourmaline Bio
8/14/2025Reiterated Rating$21.88$55.00Buy
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
8/1/2025Boost Price Target$545.46$815.00Buy
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
8/1/2025Boost Price Target$126.03$175.00Buy
argenex SE stock logo
ARGX
argenex
8/1/2025Boost Price Target$667.75$1,070.00Buy
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
7/23/2025Boost Price Target$10.00$101.00Buy
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
6/24/2025Reiterated Rating$2.42$26.00Buy
Alumis Inc. stock logo
ALMS
Alumis
6/10/2025Upgrade$3.43$18.00Buy
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
5/28/2025Reiterated Rating$21.95$90.00Buy
Vigil Neuroscience, Inc. stock logo
VIGL
Vigil Neuroscience
5/22/2025Set Price Target$7.88$8.00Neutral
Cabaletta Bio, Inc. stock logo
CABA
Cabaletta Bio
5/15/2025Boost Price Target$1.70$25.00Buy
argenex SE stock logo
ARGX
argenex
5/9/2025Lower Price Target$547.89$1,065.00Buy
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
5/6/2025Boost Price Target$20.97$54.00Buy
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
5/6/2025Boost Price Target$125.03$165.00Buy
Phathom Pharmaceuticals, Inc. stock logo
PHAT
Phathom Pharmaceuticals
5/2/2025Lower Price Target$2.76$12.00Buy
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
5/1/2025Lower Price Target$589.21$810.00Buy
Phathom Pharmaceuticals, Inc. stock logo
PHAT
Phathom Pharmaceuticals
4/2/2025Reiterated Rating$5.98Buy
Cabaletta Bio, Inc. stock logo
CABA
Cabaletta Bio
4/1/2025Reiterated Rating$1.32$23.00Buy
Trump's gold order: the announcement they won't put on the front page (Ad)

On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.tc pixel

Request the free guide in 30 seconds and get positioned now
Zura Bio Limited stock logo
ZURA
Zura Bio
3/26/2025Reiterated Rating$1.37$15.00Buy
InflaRx N.V. stock logo
IFRX
InflaRx
3/26/2025Boost Price Target$1.33$10.00Buy
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
3/25/2025Reiterated Rating$2.29$26.00Buy
Immunovant, Inc. stock logo
IMVT
Immunovant
3/20/2025Reiterated Rating$18.84Buy
Dianthus Therapeutics, Inc. stock logo
DNTH
Dianthus Therapeutics
3/12/2025Reiterated Rating$23.06$84.00Buy
argenex SE stock logo
ARGX
argenex
3/10/2025Boost Price Target$575.37$1,100.00Buy
Immunovant, Inc. stock logo
IMVT
Immunovant
3/10/2025Reiterated Rating$20.28Buy
Neumora Therapeutics, Inc. stock logo
NMRA
Neumora Therapeutics
3/7/2025Downgrade$1.52Neutral
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
2/10/2025Lower Price Target$122.62$163.00Buy
Immunovant, Inc. stock logo
IMVT
Immunovant
2/10/2025Lower Price Target$20.41$44.00Buy
Vigil Neuroscience, Inc. stock logo
VIGL
Vigil Neuroscience
1/24/2025Reiterated Rating$2.49Buy